WOOLBRO (DISTRIBUTION) LIMITED

Company number 02976465 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: B+ (Good with Minor Symptoms of Strain)

WOOLBRO (DISTRIBUTION) LIMITED presents a robust and improving financial constitution, characterized by strong asset growth and a significant surge in cash reserves. However, beneath the surface, there are symptoms of a sluggish working capital cycle—specifically, high inventory levels and a sudden, dramatic reliance on trade creditor financing. The patient is healthy but needs a regimen to improve operational efficiency before the strain shows.


1. Key Vital Signs

  • Equity Growth (The Immune System): Shareholders' funds have grown consistently from £615k in 2018 to £1.52M in 2025. This steady accumulation of retained profits indicates a strong, resilient core that protects the business against economic shocks.
  • Cash Position (Blood Circulation): Cash at bank skyrocketed from £187,947 in 2024 to £705,379 in 2025—a 275% increase. A strong cash pulse is excellent for financial stamina.
  • Liquidity Ratio (Blood Pressure): Current Assets (£3.79M) vs. Current Liabilities (£2.38M) yields a current ratio of 1.59:1. This is a healthy reading, indicating the company can comfortably cover its short-term debts.
  • Debt Leverage (Cholesterol Levels): The company has completely cleared its bank loans and overdrafts (down from £64k in 2024 to £0 in 2025). This reduction in financial "bad cholesterol" significantly lowers risk.

2. Symptoms Analysis

While the top-line numbers look healthy, a deeper examination reveals some underlying symptoms that require monitoring:

  • Swollen Inventory (Fluid Retention): Stock levels sit at £1.75M, representing nearly 45% of total assets. For a wholesale distributor, holding this much inventory ties up capital and increases the risk of write-downs for obsolete or slow-moving goods.
  • Rising Trade Debtors (Clogged Arteries): Trade debtors increased from £917k to £1.06M. While sales growth often drives this, if customers are taking longer to pay, it restricts the company's cash flow.
  • Trade Creditor Spike (Short-Term Medication): The most glaring symptom is the explosion in trade creditors (suppliers owed money), which surged from £57k in 2024 to £498k in 2025. This explains the massive increase in cash reserves—the company has essentially stopped paying its suppliers on time to boost its bank balance. While this is a common short-term tactic, it is not a sustainable long-term financial diet and risks damaging supplier relationships.

3. Diagnosis

Chronic Inventory Holding, Acute Creditor Stretching, and Underlying Debtor Inflation

The business is fundamentally profitable and has built strong equity over its 30-year history. The recent elimination of bank debt is a positive milestone. However, the 2025 financial picture shows a business that is "asset heavy." The impressive cash position is heavily reliant on stretching supplier payments. The working capital cycle is currently imbalanced: the company is holding excessive stock and allowing debtors to grow, while simultaneously delaying payments to its own suppliers to free up cash.

The presence of £170k owed by group undertakings and large "other creditors" also suggests complex inter-company financing, typical of a subsidiary owned by Rapide International Limited, but this must be managed to ensure it doesn't obscure the core operating health.


4. Recommendations

To move from good to excellent financial health, the company should adopt the following financial wellness plan:

  1. Inventory Detox: Conduct a rigorous review of the £1.75M stock holding. Identify slow-moving or obsolete inventory and consider liquidating it to free up working capital. A wholesale business should aim for higher stock turnover.
  2. Debtor Cardio (Credit Control): Tighten credit control procedures. The £1.06M in trade debtors needs to be collected faster. Consider early payment discounts for customers or stricter enforcement of payment terms to convert sales into cash more rapidly.
  3. Creditor Rehabilitation: The reliance on £498k in trade creditors to fund operations is a risky short-term fix. Develop a plan to normalize supplier payment terms. Stretching suppliers too far can lead to restricted credit terms, loss of discounts, or supply interruptions.
  4. Monitor Group Exposures: Keep a close eye on the £170k owed by group undertakings. Ensure this inter-company debt is managed on commercial terms and doesn't represent a permanent drain on the company's resources.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 14 August 2026